XTalks

JUNE 14, 2023

Novaliq, a biopharmaceutical company specializing in ocular therapeutics, recently announced that their product Vevye (cyclosporine ophthalmic solution) 0.1 percent received approval from the US Food and Drug Administration (FDA) to treat dry eye disease. As a water-free product, it does not have an associated pH value or osmolarity.

Gene Silencing 97

Gene Silencing Drug Delivery FDA Approval RNA 97

The Pharma Data

NOVEMBER 2, 2020

Research agreement to investigate the feasibility of a proprietary biotechnology process for the industrial production of psilocybin API. XPhyto is currently focused on securing industrial scale production of psychedelic APIs and the standardization of drug formulations for the delivery of such APIs.

Production 52

Production Development Drug Delivery Drugs 52

Pharmaceutical Technology

OCTOBER 26, 2022

It indicates that nanomedicine also has the potential to combat the threat of antibiotic resistance via the use of nanomaterials with intrinsic antibacterial properties, as well as using nanoparticles as effective drug delivery systems for antibacterial agents. No mock-up is necessary, saving weeks of time and considerable costs.

Manufacturing 130

Manufacturing Drug Delivery Systems Contamination Drug Delivery 130

FDA Law Blog

JUNE 13, 2024

As we explained back in March , Teva had initiated Hatch-Waxman pre-launch patent litigation against Amneal for infringement of 5 Orange Book-listed patents reading on the device constituent (a metered dose inhaler) of Teva’s combination product ProAir HFA. b)(1) that drug product patents may be listed if they claim the “drug product.

Drug Delivery Systems 116

Drug Delivery Systems Drugs Production Drug Delivery 116

Pharmaceutical Technology

APRIL 16, 2023

Autoinjectors have revolutionised the convenient delivery of low-volume parenteral drugs. Traditionally, autoinjector combination products have been limited to injection volumes of 0.1 mL or less and use a prefilled syringe (PFS) with a staked needle as the drug’s primary container. mL, with the world’s first 2.0

Protein 130

Protein Containment Drug Delivery Drugs 130

XTalks

MAY 30, 2023

The patch itself is made of biodegradable nanocellulose and contains no plastic additives. The healthcare industry has one of the heaviest environmental footprints, and manufacturers are increasingly faced with regulations to make more sustainable products,” said Mohammad H. Behfar, senior scientist at VTT, in the news release.

Drug Delivery 98

Drug Delivery Drug Delivery Systems Manufacturing Contamination 98

STAT News

NOVEMBER 3, 2022

As always, we hope your day is productive and meaningful. The companies allege Moderna’s vaccine uses their technology for a drug-delivery system without permission. Citing Our choice today is the ever-seasonal pumpkin spice, for those tracking this sort of thing. And please do keep in touch.

Vaccine 97

Vaccine Vaccination Drug Delivery Systems Sales 97

Roots Analysis

MAY 24, 2024

In the dynamic landscape of the healthcare sector, the evolution of drug delivery systems plays a significant role in transforming the management of chronic diseases. They are generally used in combination with primary containers, such as prefilled syringes and cartridges.

Drug Delivery 40

Drug Delivery Containment Contamination Production 40

pharmaphorum

NOVEMBER 17, 2021

The Future of Drug Delivery and Combination Product Device Design. The pre-filled syringes industry is growing at an exponential rate with innovations in parenteral delivery device development to aid self-administration and deliver biologics, high concentration, and large-volume drug products.

Drugs 52

Drugs Drug Delivery Engineer Production 52

The Pharma Data

OCTOBER 27, 2020

The test is planned for commercial launch as a CE-IVD ( in vitro diagnostic) certified product in the European Union in Q1 2021. “Applying 3a’s proprietary enhanced RNA technology to PCR testing was a logical next step in our product development pipeline,” said Dr. Heinrich Jehle, managing director of 3a-Diagnostics.

RNA 52

RNA Drug Delivery Production In-Vitro 52

XTalks

MAY 18, 2023

The wireless charger — the transmitter — contains a metallic coil that converts electrical energy into a magnetic field, which is then collected and reverted into electricity by the receiver inside the implanted device.

Development 96

Development Packaging Packaging Manufacturing 96

The Pharma Data

DECEMBER 20, 2020

It is our continual objective to broaden our product scope, and Transcend, with its experienced management team, is a perfect foothold for us in the fast-growing market for psychedelics molecules and complements our existing pipeline of treatments. per share, with the transaction valued at $10 million. “We About BetterLife Pharma Inc.

Drug Delivery 52

Drug Delivery Containment Production Development 52

The Pharma Data

JANUARY 27, 2021

CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT ) (“ XPhyto ” or the “ Company “) is pleased to announce its drug formulation and delivery business strategy and milestones for 2021. Pending positive results, the Company plans to advance the products toward a final pivotal study and application for regulatory approval.

Drugs 52

Drugs Manufacturing Drug Delivery Production 52

Roots Analysis

JANUARY 17, 2024

They offer several advantages over traditional drug delivery systems ( such as vials and syringes ), including reduced chances of dosing errors, increased patient compliance and decreased risk of microbial contamination. However, this needle system does not contain a proper locking system, therefore, increased the chances of leakage.

Drug Delivery 40

Drug Delivery Contamination Drugs Production 40

The Pharma Data

DECEMBER 28, 2020

is an emerging biotechnology company engaged in the development and commercialization of therapeutic pharmaceuticals as well as drug delivery platform technologies. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. About BetterLife Pharma Inc. BetterLife Pharma Inc.

Containment 52

Containment Drug Delivery Compliance Marketing 52

The Pharma Data

JANUARY 3, 2021

With the demand for inhalable products heightening, TLC established a subsidiary, allocating its inhalation technical expertise for financing by strategic investors in order to raise funds needed for the expedited research and development of TLC19 and other inhalable programs. Source link.

Clinical Trials 52

Clinical Trials Clinical Trials Containment Development 52

The Pharma Data

JANUARY 25, 2021

The Company is focused on its realigned strategy for its Q-Sphera technology and MTX110 and will continue to pursue licensing opportunities for its products and/or technologies. We are well positioned for a productive 2021.” Our Q-Sphera pipeline is significantly expanded, providing more opportunities for partnering success.

Containment 52

Containment Drug Delivery Licensing Licensing 52

The Pharma Data

JANUARY 27, 2021

This approach makes Eurofins Discovery uniquely qualified to fulfill the needed studies for this innovative product. is an emerging biotechnology company engaged in the development and commercialization of next generation psychedelic products for the treatment of mental disorders. About BetterLife Pharma: BetterLife Pharma Inc.

In-Vitro 52

In-Vitro Containment Drugs Production 52

The Pharma Data

JANUARY 18, 2021

“Confirmation of the non-controlled status of 2-bromo-LSD is a significant first step for BetterLife to initiate our IND-enabling pre-clinical studies of our lead second-generation psychedelic product TD-0148A. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.

Containment 40

Containment Production Drug Delivery Regulation 40

Druggist

NOVEMBER 19, 2020

As we already learned from the above combination inhaler in asthma contains two ingredients, one of which is inhaled corticosteroid and the other LABA. The Medicines and Healthcare products Regulatory Agency (MHRA) recommends that LABA should always be taken with inhaled corticosteroids. What is a combination inhaler? Able Spacer®.

Pharmacy 69

Pharmacy Doctor Doctors Licensing 69

XTalks

AUGUST 30, 2022

The pharmaceutical industry deals with threats such as product liability, cyberthreats, supply chain disruptions, competition from generic drugs and more. Although these leadership styles are of very different natures, they also contain some commonalities. Transformational Leadership. Final Thoughts on Leadership Styles.

Life Science 105

Life Science Generic Drugs Drug Delivery Compliance 105

The Pharma Data

JANUARY 31, 2021

Ryan Egeland, MD, PhD, CSI’s Chief Medical Officer, said, “This partnership is consistent with our strategic vision to develop an innovative portfolio of new products. We believe these next generation DCBs will complement our current and growing portfolio of products for the treatment of complex coronary and peripheral disease.

Development 52

Development Drugs Production Containment 52

Roots Analysis

JUNE 6, 2024

Such deals are inked to not only allow companies to expand their respective product portfolios, but also gain additional capabilities related to emerging technologies. Notably, product development agreements emerged as the most popular type of partnership model adopted by stakeholders in the autoinjectors domain.

Medicine 40

Medicine Drug Delivery Manufacturing Marketing 40

The Pharma Data

OCTOBER 27, 2020

The product listing offered on Amazon.ca Now with the distribution by Amazon there will be greater access for Canadians as well as quicker delivery times, especially for an important product like DermSafe that will help people fight the battle against this pandemic,” said Mr. Terry Howlett, President of Ovation.

Sales 52

Sales Production Drug Delivery Development 52

The Pharma Data

JANUARY 17, 2021

Clinical validation of transdermal and sublingual drug formulations. Psychedelic API production, drug formulation and clinical integration. The Company is on the cusp of transformational change as product development programs advance from the laboratory to the clinic. Diagnostics.

Production 40

Production Development Drug Delivery Drugs 40

The Pharma Data

JANUARY 3, 2021

to have in place 25 operating production lines of which 5 to 10 are expected to be GMP production lines. Nanoform’s capabilities span the small to large molecule development space and the company focuses on solving key issues in drug solubility and bioavailability and on enabling novel drug delivery applications.

Containment 40

Containment Bioavailability Clinical Trials Clinical Trials 40

The Pharma Data

OCTOBER 20, 2020

” Mr. Bliss joins TLC following interim roles in cellular therapy, drug delivery and combination therapy where he led efforts to confirm research outcomes and partner the various technologies. This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.

Licensing 40

Licensing Licensing Drug Delivery Business Development 40

The Pharma Data

NOVEMBER 4, 2020

He is an experienced chairman and board member of numerous European industry associations and companies and is the co-founder and current chairman of Curida AS , a Norwegian-based contract development manufacturing organization focused on liquid pharmaceutical production. Thoresen is an important addition to XPhyto’s board of directors.

Drug Delivery 40

Drug Delivery Production Manufacturing Development 40

The Pharma Data

NOVEMBER 26, 2020

There are significant challenges in drug development in this space and we look forward to working closely with pharma and biotech partners to discover how we can add value to their programs, provide patient benefit and competitive product differentiation.” ” Prof. For more information please visit [link].

Containment 52

Containment Medicine Development Bioavailability 52

The Pharma Data

NOVEMBER 9, 2020

is accelerating the next-generation drug delivery, diagnostic, and phytochemical investment opportunities: precision transdermal and oral dissolvable drug dosage forms; rapid, low-cost infectious disease and oral health screening tools; and validation of approved cannabinoid-based therapeutics focused on European markets.

Development 40

Development Drugs Drug Delivery Production 40

The Pharma Data

NOVEMBER 4, 2020

Ltd (“Juyou”), a biotechnology company that develops and sells medical and cosmetic skincare products, for the commercialization and development of Pliaglis ® in mainland China (the “License Agreement”). million and US$1.8 About Juyou Bio – Technology Co. Juyou Bio-Technology Co.,

Licensing 40

Licensing Licensing Dermatology Production 40

The Pharma Data

DECEMBER 14, 2020

is an emerging biotechnology company engaged in the development and commercialization of therapeutic pharmaceuticals as well as drug delivery platform technologies. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. About BetterLife Pharma Inc. BetterLife Pharma Inc.

Drug Delivery 40

Drug Delivery Containment Manufacturing Drugs 40

The Pharma Data

DECEMBER 17, 2020

In addition, TLC is preparing for scale-up production of TLC590, as for complex lipid products, the manufacturing process and batch size used in pivotal clinical trials and New Drug Application submission must be the same as future commercial batches. Cautionary Note on Forward-Looking Statements.

Clinical Trials 40

Clinical Trials Clinical Trials Trials Containment 40

FDA Law Blog

MARCH 12, 2024

Koblitz — After years of silence from FDA on whether certain patents could be listed in the Orange Book, some manufacturers of drug and device combination products have had a rude awakening lately.

Drugs 45

Drugs Drug Delivery Systems Regulation Production 45

Roots Analysis

MARCH 16, 2023

In the last few years, researchers have become interested in using in vitro transcribed (IVT) mRNA as a drug delivery agent. Prevention of infectious diseases: Development of a prophylactic or therapeutic vaccine is one of the most effective ways to contain and fight an epidemic / pandemic.

Vaccine 52

Vaccine Vaccination DNA Protein 52

The Pharma Data

DECEMBER 2, 2020

Progenity”) (NASDAQ: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing products, today announced the pricing of its previously announced underwritten public offering of 7,645,259 shares of its common stock at a public offering price of $3.27 SAN DIEGO, Dec.

In-Vitro 40

In-Vitro Sales Containment Development 40

The Pharma Data

JUNE 26, 2021

Roche’s Chief Medical Officer and Head of Global Product Development. “If About Port Delivery System with ranibizumab (PDS) PDS is a permanent refillable eye implant, approximately the size of a grain of rice, which is designed to continuously release a customised formulation of ranibizumab into the eye over time.

Drug Delivery 52

Drug Delivery Clinical Trials Clinical Trials Medicine 52